HCPCS Level IIdrugActive
J0637
Caspofungin acetate
BETOS: O1E
Effective: 2024-01-01
Description
Injection, caspofungin acetate, 5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Cancidas
Manufacturer
Merck Sharp & Dohme LLC
HCPCS Dosage
5 MG
Billing Units
10.0000
15
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.